Johnson & Johnson Articles
EMEA recommends new warnings on epoetins
7 July 2008
Xarelto could set new gold standard in VTE
7 July 2008
Millennium/J&J's FDA approval for Velcade
30 June 2008
J&J buys Swedish POC firm Amic for $40M
30 June 2008
FDA expert panel votes to approve Centocor
23 June 2008
FDA approves IND for HalcyGen's SUBA-Itraconazole
23 June 2008
J&J psoriasis candidate may cause cancer; FDA
23 June 2008
J&J's tapentadol improves GI tolerability
23 June 2008
RA golimumab patients see DAS28 remissions
23 June 2008
Cancer death risk label for J&J's Regranex
16 June 2008
Astex and Janssen form $500M alliance
16 June 2008
Rivaroxaban beats Lovenox: RECORD4 trial
16 June 2008
J&J's Doribax gets CHMP OK for NP
9 June 2008
EC targets Sanofi for "obstruction"
9 June 2008
Alkermes' fiscal-2008 income soars on Reliant
9 June 2008
PharmaMar's Yondelis cleared in South Korea
19 May 2008
Hospira launches Retacrit in UK
19 May 2008
J&J drug: longer time to relapse than quetiapine
12 May 2008
New effort to curb DTC ads by US Democrats
12 May 2008
UK blocks Remicade for UC to NHS patients
5 May 2008
Wyeth withdraws US CAP Tygacil application
5 May 2008
Stock Commentary - New York week to April 21, 2008
28 April 2008
New Rx drug pricing models for UK
21 April 2008
7TM gets milestone from Ortho-McNeil
21 April 2008
FDA pre-emption fears raised for drug law suits
14 April 2008
Millennium accepts $8.8B bid from Takeda
14 April 2008
Swissmedic grants PharmaMar
7 April 2008
ARCA renames to reflect new focus
7 April 2008
FDA launches safety review of J&J's Regranex
7 April 2008
E-mail drug alerts for US physicians launched
31 March 2008
EMEA restricts use of Millennium/J&J's Velcade
31 March 2008
Delay to ceftobiprole's US approval
24 March 2008
Galapagos' FY 2007 loss almost doubles on R&D
24 March 2008
PharmaMar's Yondelis enters Ph II COG trial
24 March 2008
Ortho modifies Procrit Rxing info
17 March 2008
Endo names David Holveck as president and CEO
17 March 2008
FDA extends review of J&J's Doribax
17 March 2008
FDA priority review for Eisai's Aciphex
10 March 2008
Centocor's psoriasis drug accepted for FDA review
10 March 2008
PDCO recommends PIPs for four drugs
3 March 2008
Pharma seen as good employer, survey finds
25 February 2008
Alex Gorsky leaves Novartis to join J&J's Ethicon
25 February 2008
Sunesis gets milestone in J&J accord
25 February 2008
J&J/Actavis recall US lots of fentanyl patches
25 February 2008
Generic Rxing hits 65% of US market
25 February 2008
Basilea's 2007 loss up 55% on trial costs
18 February 2008
Millennium's 2007 net income beats forecasts
18 February 2008
Entelos expects flat revenues for 2007
11 February 2008
Ustekinumab boosts 12-week PASI-75 scores
11 February 2008
Galapagos NV gets $4.9M milestone under Janssen RA drug alliance
4 February 2008
Stock Commentary - New York week to Jan 28, 2008
4 February 2008
David Powell appointed representative director and president of Johnson & Johnson KK
28 January 2008
Pfizer sees 4th-qtr 2007 profits decline, but still beats forecasts; revenue rises 4%
28 January 2008
J&J's 4th-qtr 2007 sales jump 16.6%, EPS up 11%
28 January 2008
FDA tightens warning on J&J's Ortho Evra patch
28 January 2008
UPDATE: Raids on major drugmakers as EU Commission starts pharma sector inquiry with unannounced inspections
21 January 2008
Velcade helps exceed Millennium's targets
14 January 2008
UK Parliament c'tee calls for NICE review
14 January 2008
Biovail and Janssen sign tramadol supply and distribution accord
14 January 2008
ImmunoGen to develop anticancer TAP compound based on Ab developed by J&J's Centocor unit
14 January 2008
German generics see drug majors cut prices
14 January 2008
US Public Citizen group sues the FDA over antibiotics warnings
14 January 2008
Patent expiry for 2008 provides generic opportunity
14 January 2008
Akela expands Taifun deal to include Canada
7 January 2008
Millennium to get $40M milestone from Ortho Biotech
7 January 2008
Stock Commentary - New York week to Dec 10, 2007
17 December 2007
Ustekinumab submitted for marketing review in EU and USA
17 December 2007
Amgen in discussions to update US ESA labels
17 December 2007
PhRMA details Mexico flood relief by members
17 December 2007
Japan stock market week to Nov 19, 2007
26 November 2007
FDA OKs non-Rx sale of allergy drug Zyrtec
26 November 2007
CHMP issues negative view on Cimzia in Crohn's
26 November 2007
Millennium's 3rd-qtr loss down 88%
21 November 2007
PH III Xarelto data to be presented at ASH
19 November 2007
"Devastating" AS ruling by the NICE condemned
19 November 2007
US FDA clears J&J's non-Rx Zyrtec
19 November 2007
Chiesi and Abbott sign drug co-promotion deal
19 November 2007
Court rejects J&J claim against Red Cross
19 November 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
